Dudman S - Search Results

1

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment.

Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A. Yri OE, et al. Among authors: dudman s. Blood. 2011 Dec 22;118(26):6769-71. doi: 10.1182/blood-2011-08-372649. Epub 2011 Nov 4. Blood. 2011. PMID: 22058114 Free article.

2

Antibiotic Consumption in a Cohort of Hospitalized Adults with Viral Respiratory Tract Infection.

Debes S, Haug JB, De Blasio BF, Lindstrøm JC, Jonassen CM, Dudman SG. Debes S, et al. Among authors: dudman sg. Antibiotics (Basel). 2023 Apr 20;12(4):788. doi: 10.3390/antibiotics12040788. Antibiotics (Basel). 2023. PMID: 37107150 Free PMC article.

3

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC. Lackenby A, et al. Among authors: dudman sg. Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en. Euro Surveill. 2008. PMID: 18445375 Free article. No abstract available.

4

[Resistance in influenza viruses].

Hungnes O, Dudman SG. Hungnes O, et al. Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2601-6. Tidsskr Nor Laegeforen. 2008. PMID: 19023375 Free article. Review. Norwegian.

5

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Hauge SH, et al. Among authors: dudman s. Emerg Infect Dis. 2009 Feb;15(2):155-62. doi: 10.3201/eid1502.081031. Emerg Infect Dis. 2009. PMID: 19193257 Free PMC article.

6

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.

Hauge SH, Blix HS, Borgen K, Hungnes O, Dudman SG, Aavitsland P. Hauge SH, et al. Among authors: dudman sg. Virol J. 2009 May 12;6:54. doi: 10.1186/1743-422X-6-54. Virol J. 2009. PMID: 19435505 Free PMC article.

7

[Disease caused by the new influenza A(H1N1) virus].

Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P. Hauge SH, et al. Tidsskr Nor Laegeforen. 2009 Sep 10;129(17):1736-9. doi: 10.4045/tidsskr.09.0748. Tidsskr Nor Laegeforen. 2009. PMID: 19756053 Free article. Review. Norwegian.

8

Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010.

Kilander A, Rykkvin R, Dudman SG, Hungnes O. Kilander A, et al. Among authors: dudman sg. Euro Surveill. 2010 Mar 4;15(9):19498. doi: 10.2807/ese.15.09.19498-en. Euro Surveill. 2010. PMID: 20214869 Free article.

9

High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.

Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, Hungnes O. Waalen K, et al. Among authors: dudman sg. Euro Surveill. 2010 Aug 5;15(31):19633. Euro Surveill. 2010. PMID: 20738992 Free article.

10

[Wrongly informed about influenza serology].

Vik IS, Dudman SG, Hungnes O, Hoddevik G. Vik IS, et al. Tidsskr Nor Laegeforen. 2011 Jan 21;131(2):110-1. doi: 10.4045/tidsskr.10.1298. Tidsskr Nor Laegeforen. 2011. PMID: 21267019 Free article. Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page